Breaking News Instant updates and real-time market news.

CRNX

Crinetics

$25.39

0.38 (1.52%)

07:36
03/19/19
03/19
07:36
03/19/19
07:36

Crinetics doses first patient in ACROBAT EVOLVE, EDGE trials for CRN00808

Crinetics announced the dosing of the first patients in the ACROBAT EVOLVE and EDGE trials for CRN00808 in patients with acromegaly. EVOLVE is a double-blind, placebo-controlled, randomized withdrawal study designed to evaluate the safety, efficacy, and pharmacokinetics of CRN00808, an oral selective nonpeptide somatostatin receptor type 2 biased agonist, in patients with acromegaly that are responders to octreotide LAR or lanreotide depot monotherapy. EDGE is an open label exploratory study designed to evaluate the safety, efficacy and pharmacokinetics of CRN00808 in patients with acromegaly whose disease is inadequately controlled by octreotide LAR or lanreotide depot alone.

CRNX Crinetics
$25.39

0.38 (1.52%)

02/14/19
HCWC
02/14/19
INITIATION
Target $35
HCWC
Buy
Crinetics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Douglas Tsao started Crinetics with a Buy rating and $35 price target. Crinetics' lead asset, CRN00808, has the potential to take leadership in acromegaly, but CRN01941 for the treatment of neurondocrine tumors is the "real driver of value," Tsao tells investors in a research note. He sees peak sales of $211M for CRN00808 and peak sales of $1.6B for CRN01941.
03/11/19
CANT
03/11/19
INITIATION
Target $40
CANT
Overweight
Crinetics initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Charles Duncan initiated Crinetics with an Overweight and $40 price target.
03/12/19
CANT
03/12/19
INITIATION
Target $40
CANT
Overweight
Cantor starts Crinetics with Overweight rating, $40 price target
Cantor Fitzgerald analyst Charles Duncan last night initiated coverage of Crinetics Pharmaceuticals with an Overweight rating and $40 price target. The analyst believes Crinetics has "proven expertise" in endocrinology and is focusing on neuro-endocrine disorders that have "well-established etiology" for which there are no or limited oral agents that can selectively modulate activity. He sees the two Phase 2 Acrobat studies as "attractive risk/reward value drivers" in the next 12 months.
03/12/19
03/12/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Snap (SNAP) initiated with an Overweight at Consumer Edge. 2. Crinetics (CRNX) initiated with an Overweight at Cantor Fitzgerald. 3. Tellurian (TELL) initiated with a Buy at BTIG. 4. Stealth Biotherapeutics (MITO) initiated with an Outperform at Evercore ISI, a Buy at Nomura Instinet, and a Hold at Jefferies. 5. Resideo (REZI) initiated with an Outperform at Imperial Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

NFLX

Netflix

$286.83

2.59 (0.91%)

, DIS

Disney

$130.95

1.18 (0.91%)

06:12
10/17/19
10/17
06:12
10/17/19
06:12
Downgrade
Macquarie downgrades Netflix to Neutral on slowing U.S. growth »

Macquarie analyst Tim…

NFLX

Netflix

$286.83

2.59 (0.91%)

DIS

Disney

$130.95

1.18 (0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 29

    Oct

  • 07

    Nov

NFLX

Netflix

$286.83

2.59 (0.91%)

06:12
10/17/19
10/17
06:12
10/17/19
06:12
Recommendations
Netflix analyst commentary  »

Netflix remains long-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

MUX

McEwen Mining

$1.50

0.015 (1.01%)

06:12
10/17/19
10/17
06:12
10/17/19
06:12
Hot Stocks
McEwen Mining reports Q3 production 45,930 gold equivalent ounces »

McEwen Mining reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLL

Whiting Petroleum

$6.65

-0.07 (-1.04%)

06:11
10/17/19
10/17
06:11
10/17/19
06:11
Upgrade
Whiting Petroleum rating change  »

Whiting Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 06

    Nov

IGLD

Internet Gold

$18.90

(0.00%)

06:08
10/17/19
10/17
06:08
10/17/19
06:08
Hot Stocks
Internet Gold sees Searchlight Transaction closing on November 7 »

Internet Gold announced,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STI

SunTrust

$68.28

0.23 (0.34%)

06:07
10/17/19
10/17
06:07
10/17/19
06:07
Earnings
SunTrust reports Q3 EPS $1.34, consensus $1.41 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 12

    Nov

ERIC

Ericsson

$8.63

0.175 (2.07%)

06:07
10/17/19
10/17
06:07
10/17/19
06:07
Conference/Events
Ericsson to host investor update conference call »

Conference call to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

UNTY

Unity Bancorp

$21.12

-0.45 (-2.09%)

06:06
10/17/19
10/17
06:06
10/17/19
06:06
Earnings
Breaking Earnings news story on Unity Bancorp »

Unity Bancorp reports Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$9.06

-0.02 (-0.22%)

, AMZN

Amazon.com

$1,777.43

8.73 (0.49%)

06:06
10/17/19
10/17
06:06
10/17/19
06:06
Hot Stocks
Ford introduces North America's largest electric vehicle charging network »

Ford (F) is offering its…

F

Ford

$9.06

-0.02 (-0.22%)

AMZN

Amazon.com

$1,777.43

8.73 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 21

    Nov

CREE

Cree

$47.37

-1.38 (-2.83%)

06:06
10/17/19
10/17
06:06
10/17/19
06:06
Recommendations
Cree analyst commentary  »

Cree guidance to miss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 30

    Oct

WNS

WNS Holdings

$60.62

0.85 (1.42%)

06:04
10/17/19
10/17
06:04
10/17/19
06:04
Earnings
WNS Holdings sees FY20 adjusted EPS $2.93-$3.08, consensus $2.88 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 11

    Nov

WNS

WNS Holdings

$60.62

0.85 (1.42%)

06:03
10/17/19
10/17
06:03
10/17/19
06:03
Earnings
WNS Holdings reports Q2 adjusted EPS 79c, consensus 67c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 11

    Nov

CMA

Comerica

$65.50

-1.505 (-2.25%)

06:02
10/17/19
10/17
06:02
10/17/19
06:02
Downgrade
Comerica rating change  »

Comerica downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNB

F.N.B.

$12.02

0.09 (0.75%)

06:01
10/17/19
10/17
06:01
10/17/19
06:01
Earnings
F.N.B. reports Q3 EPS 31c, consensus 29c »

Reports Q3 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 13

    Nov

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$298.46

-0.44 (-0.15%)

05:58
10/17/19
10/17
05:58
10/17/19
05:58
General news
Boris Johnson announces 'great new' Brexit deal »

Prime Minister of the…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$298.46

-0.44 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$298.46

-0.44 (-0.15%)

05:55
10/17/19
10/17
05:55
10/17/19
05:55
General news
European Commission President says Brexit deal has been reached »

President of the European…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$298.46

-0.44 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEGRY

Weir Group

$0.00

(0.00%)

05:51
10/17/19
10/17
05:51
10/17/19
05:51
Downgrade
Weir Group rating change  »

Weir Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPHHF

Sophos Group

$0.00

(0.00%)

05:50
10/17/19
10/17
05:50
10/17/19
05:50
Downgrade
Sophos Group rating change  »

Sophos Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASOMY

Asos

$0.00

(0.00%)

05:49
10/17/19
10/17
05:49
10/17/19
05:49
Upgrade
Asos rating change  »

Asos upgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

BC

Brunswick

$55.47

0.46 (0.84%)

05:48
10/17/19
10/17
05:48
10/17/19
05:48
Downgrade
Brunswick rating change  »

Brunswick downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

BBT

BB&T

$53.00

0.25 (0.47%)

05:47
10/17/19
10/17
05:47
10/17/19
05:47
Earnings
BB&T reports Q3 adj. EPS $1.07, consensus $1.03 »

Reports Q3 revenue $3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 08

    Nov

ASML

ASML

$254.52

-13.04 (-4.87%)

05:45
10/17/19
10/17
05:45
10/17/19
05:45
Downgrade
ASML rating change  »

ASML downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

PFBC

Preferred Bank

05:43
10/17/19
10/17
05:43
10/17/19
05:43
Downgrade
Preferred Bank rating change  »

Preferred Bank downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

SAM

Boston Beer

$382.92

-4.92 (-1.27%)

05:41
10/17/19
10/17
05:41
10/17/19
05:41
Upgrade
Boston Beer rating change  »

Boston Beer upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

SBNY

Signature Bank

$118.68

-0.1 (-0.08%)

05:41
10/17/19
10/17
05:41
10/17/19
05:41
Earnings
Signature Bank reports Q3 EPS $2.75, consensus $2.70 »

Reports Q3 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 29

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.